High levels of leukaemia inhibitory factor in ARDS

Cytokine

Volumn 8, Issue 11, 1996, Pages 873-876

  Jorens, Philippe G ^a   De Jongh, Raf ^b   Bossaert, Leo L ^a   De Backer, Wilfried ^a   Herman, Arnold G ^a   Pollet, H ^c   Bosmans, E ^c   Taupin, J L ^d   Moreau, J F ^d  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Dept of Intensive Care Medicine ^*  (Belgium)

^c Eurogenetics   (Belgium)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOKINE; LEUKEMIA INHIBITORY FACTOR; PROTEIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; INFLAMMATION; LUNG LAVAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0030295343     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.9999     Document Type: Article

References (25)

1. 1. Fowler AA, Hamman RF, Good TJ, Benson KN, Baird M, Eberle DJ, Petty TL, Hyers TM (1983) Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 98:593-597.
2. 2. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg A (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Resp Crit Care Med 149:818-824.
3. 3. Kollef MH, Schuster DP (1995) The acute respiratory distress syndrome. N Engl J Med 332:27-37.
4. 4. Rinaldo JE, Christman JW (1990) Mechanisms and mediators of the adult respiratory distress syndrome. Clin Chest Med 11:621-632.
5. 5. Steinberg KP, Mitchell DR, Maunder RJ, Milberg JA, Whitcomb ME, Hudson LD (1993) Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Resp Dis 148:556-561.
6. 6. Millar AB, Singer M, Meager A, Foley NM, Johnson NM, Rook GAW (1989) Tumour necrosis factor in bronchopulmonary secretions of patients with the adult respiratory distress syndrome. The Lancet ii:712-714.
7. 7. Siler TM, Swierkosz JE, Hyers TM, Fowler AA, Webster RO (1989) Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. Exp Lung Res 15:881-894.
8. 8. Jorens PG, Van Damme J, De Backer W, Bossaert L, De Jongh RF, Herman AG, Rampart M (1992) Interleukin-8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine 4:592-597.
9. 9. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C (1993) Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. The Lancet 341:643-647.
10. 10. Moreau JF, Donaldson DD, Bennett F, Witek-Giannotti J, Clark SC, Wong GG (1988) Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature 336:690-692.
11. 11. Hilton DJ, Nicola NA, Gough NM, Metcalf D (1988) Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation-inducing activity on murine myeloid leukemic cell lines. J Biol Chem 263:9238-9243.
12. 12. Hilton DJ (1992) LIF: lots of interesting functions. Trends Biochem Sci 17:72-76.
13. 13. Villiger PM, Yeng Y Lotz M (1993) Induction of cytokine expression by leukemia inhibitory factor. J Clin Invest 91:1575-1581.
14. 14. Waring P, Wycherley K, Cary D, Nicola N, Metcalf D (1992) Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 90:2031-2037.
15. 15. Morel D, Taupin JL, Combe C, Potaux L, Gualde N, Moreau JF (1994) One-year enzyme-linked immunosorbent assay follow-up of human interleukin for Da cells/leukemia inhibitory factor in blood and urine of 22 kidney transplant recipients. Transplantation 58:1190-1195.
16. 16. Metcalf D, Gearing DP (1989) Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor (LIF). Proc Natl Acad Sci USA 86:5948-5952.
17. 17. Metcalf D, Nicola NA, Gearing DP (1990) Effect of leukemia inhibitory factor on hematopoietic and other tissues in mice. Blood 76:50-56.
18. 18. Ulich TR, Fann MJ, Patterson PH, Williams JH, Samal B, Del Castillo J, Yin S, Guo K, Remick DG (1994) Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. Am J Physiol 267:L442-L446.
19. 19. Alexander HR, Wong GGH, Doherty GM, Venzon DJ, Fraker DL, Norton JA (1992) Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor. J Exp Med 175:1139-1142.
20. 20. Waring PM, Waring LJ, Billington T, Metcalf D (1995) Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc Natl Acad Sci USA 92:1337-1341.
21. 21. Tsan MF, White JE, Wong G (1992) D-Factor and growth hormone enhance TNF-induced increase of Mn superoxide dismutase mRNA and oxygen tolerance. Cytokine 4:1101-1105.
22. 22. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. The Lancet ii:319-323.
23. 23. Rennard SI, Ghafouri MO, Thompson AB, Linder J, Vaughan W, Jones K, Ertl RF, Christensen K, Prince A, Stahl MG (1990) Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am Rev Resp Dis 141:208-217.
24. 24. Taupin JL, Acres B, Dott K, Schmitt D, Kieny MP, Gualde N, Moreau JF (1993) Immunogenicity of HILDA/LIF either in a soluble or in membrane anchored form expressed in vivo by recombinant vaccinia viruses. Scand J Immunol 38:293-301.
25. 25. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram-quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.